Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Riedel, Richard ORCID: 0000-0002-8883-1188, Ruge, Lea ORCID: 0000-0003-3390-0411, Verheyen, Malte ORCID: 0009-0008-7552-9044, John, Felix ORCID: 0000-0002-0616-3391, Scharpenseel, Heather ORCID: 0000-0001-6322-8350, Nogova, Lucia ORCID: 0000-0002-4502-1812, Michels, Sebastian ORCID: 0000-0003-3164-870X, Fischer, Rieke N. ORCID: 0009-0001-5271-2160, Eisert, Anna, Jakob, Carolin ORCID: 0009-0008-5641-6888, Niesen, Emanuel, Fassunke, Jana ORCID: 0000-0002-8391-5577, Siemanowski-Hrach, Janna ORCID: 0009-0000-8453-5229, Heydt, Carina ORCID: 0000-0003-3184-9579, Bunck, Anne, Siebolts, Udo ORCID: 0009-0000-2336-4737, Merkelbach-Bruse, Sabine ORCID: 0000-0002-0312-5760, Buettner, Reinhard ORCID: 0000-0001-8806-4786, Wolf, Jürgen ORCID: 0000-0002-3869-4736 and Scheffler, Matthias ORCID: 0000-0002-9031-1368 (2026). MET-Driven Resistance to Sotorasib in KRAS G12C–Mutant NSCLC and Response to Combined KRAS and MET Inhibition. JTO Clinical and Research Reports, 7 (3). pp. 1-7. Elsevier. ISSN 2666-3643

Stahl, David, Gödel, Philipp ORCID: 0000-0001-7887-8313, Balke-Want, Hyatt ORCID: 0000-0002-5963-7626, Gholamipoorfard, Rahil ORCID: 0000-0001-8207-7295, Segbers, Paul, Tetenborg, Luis, Koker, Mirjam, Dörr, Janina, Gregor, Lisa, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Rose, France ORCID: 0000-0001-5828-3259, Simon, Adrian G. ORCID: 0000-0002-2709-863X, Good, Zinaida, Jakob, Josefine, Häupl, Björn, Nill, Marieke, Flümann, Ruth ORCID: 0000-0002-7147-7557, Riët, Tobias ORCID: 0000-0002-8211-7071, Lange, Dinah ORCID: 0000-0002-2933-2143, Blakemore, Stuart J. ORCID: 0000-0003-2892-1162, Baurmann, Herrad, Voltin, Conrad-Amadeus, Potter, Nicole, Schlözer, Lilli, Freihammer, Max, Wagener-Ryczek, Svenja ORCID: 0000-0002-2870-5606, Iuga, Andra-Iza, Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Ludwig, Hanna, Schleifenbaum, Julia K. ORCID: 0000-0001-7204-3235, Propp, Jessica ORCID: 0009-0007-1656-5275, Bröckelmann, Paul J. ORCID: 0000-0001-9662-9900, Jachimowicz, Ron D. ORCID: 0000-0001-9522-7061, Knittel, Gero Thomas ORCID: 0000-0001-8395-3701, Borchmann, Sven ORCID: 0000-0001-6662-6864, Merkelbach-Bruse, Sabine ORCID: 0000-0002-0312-5760, Pallasch, Christian P. ORCID: 0000-0001-5675-6905, Peifer, Martin ORCID: 0000-0002-5243-5503, Rybniker, Jan ORCID: 0000-0001-8351-2690, Quaas, Alexander ORCID: 0000-0002-3537-6011, Nitz, Mark, Brägelmann, Johannes, Müller, Werner, Persigehl, Thorsten ORCID: 0000-0001-5928-4405, Bozek, Katarzyna ORCID: 0000-0002-0917-6876, Theobald, Sebastian J. ORCID: 0000-0001-7042-8326, Büttner, Reinhard ORCID: 0000-0001-8806-4786, Oellerich, Thomas ORCID: 0000-0001-6570-6125, Hallek, Michael ORCID: 0000-0002-7425-4455, Kobold, Sebastian, Chmielewski, Markus ORCID: 0000-0001-9348-5219, Reinhardt, Hans Christian ORCID: 0000-0001-5706-9349, Mackall, Crystal, Abedpour, Nima ORCID: 0000-0002-2933-8035, Borchmann, Peter ORCID: 0000-0003-3782-2158 and Ullrich, Roland T. (2025). CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma. Cancer Cell, 43 (8). 1476-1494.e10. Elsevier. ISSN 1535-6108

Michels, S. ORCID: 0000-0003-3164-870X, Massutí, B., Vasyliv, I., Stratmann, J., Frank, J., Adams, A. ORCID: 0000-0003-3286-1131, Felip, E., Grohé, C., Rodriguez-Abreu, D. ORCID: 0000-0003-0506-1366, Bischoff, H., Carcereny i Costa, E., Corral, J., Pereira, E., Fassunke, J. ORCID: 0000-0002-8391-5577, Fischer, R.N. ORCID: 0009-0001-5271-2160, Insa, A., Koleczko, S., Nogova, L. ORCID: 0000-0002-4502-1812, Reck, M. ORCID: 0000-0002-5348-4462, Reutter, T. ORCID: 0009-0001-5153-7049, Riedel, R. ORCID: 0000-0002-8883-1188, Schaufler, D., Scheffler, M. ORCID: 0000-0002-9031-1368, Weisthoff, M. ORCID: 0000-0001-6536-3898, Provencio, M., Merkelbach-Bruse, S. ORCID: 0000-0002-0312-5760, Hellmich, M. ORCID: 0000-0001-5174-928X, Sebastian, M. ORCID: 0000-0002-0404-7741, Büttner, R. ORCID: 0000-0001-8806-4786, Persigehl, T. ORCID: 0000-0001-5928-4405, Rosell, R. ORCID: 0000-0003-0817-3400 and Wolf, J. ORCID: 0000-0001-7577-464X (2024). Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial. ESMO Open, 9 (2). pp. 1-10. Elsevier. ISSN 2059-7029

This list was generated on Mon Oct 19 11:33:27 2026 CEST.